In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Seradyn Inc.

Division of Thermo Fisher Scientific Inc.

Latest From Seradyn Inc.

Sybron Quietly Builds a Powerhouse

Sybron International, hardly a well-known name in the diagnostics industry, has built a $350 million highly profitable diagnostics business by acquiring small, niche companies. Its latest acquisition, Microgenics Corp., makes it an important player in the drugs of abuse and therapeutic drug monitoring businesses. Microgenics had been part of Boehringer Mannheim Corp. But when Roche bought Boehringer Mannheim, the FTC required Roche to sell off Microgenics for anti-trust reasons. Microgenics was sold last summer to an investor group, which sold it to Sybron.
BioPharmaceutical Medical Device

Marketing Whizz

Calypte Biomedical just got approval for a urine-based HIV-1 confirmatory test, showing unbelievers that urine-based assays can be as sensitive--and even more sensitive--than traditional blood-based tests. Since the test's less dangerous for health care workers to handle, the company expects its fortunes to improve dramatically.
Medical Device
See All

Company Information